跳至主要内容
临床试验/NCT06725173
NCT06725173招募中不适用

Genetic Associations of Ocular Cancers

University of Washington1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年3月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Epigenomic and genomic profiling of the RB1 gene

研究概览

简要总结

The goal of this observational study is undertake a detailed phenotypic and genotypic study of patients with ocular and secondary cancers due to mutations in the RB1 gene. Our research sequencing approach will allow advanced insight to for further detailed genotypic understanding of parent-of-origin for valuable insight into the genotype-phenotype relationship of this cancer syndrome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with molecularly proven retinoblastoma due to RB1 or a typical clinical retinoblastoma phenotype with genetic screening pending.
  • Able to give consent/parent or guardian able to give consent.

排除标准

  • Patients unable or unwilling to undertake consent or clinical testing.
  • Patients unwilling to donate a saliva or blood sample in order to establish the genetic cause of their condition.

研究组 & 干预措施

Patients with presumed germline retinoblastoma due to RB1 mutation

干预措施: Targeted Long-read sequencing (Genetic)

结局指标

主要结局

Epigenomic and genomic profiling of the RB1 gene

时间窗: 5 years

Methylation signatures and genomic variant information to determine phase of the pathogenic variants in RB1 to specific differentially methylated signals in RB1

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Debarshi Mustafi

Assistant Professor: School of Medicine, Ophthalmology

University of Washington

研究点 (1)

Loading locations...

相似试验